The Ministry of Health's Revised Implant Subsidy Framework aims to subsidise implants in a fair and sustainable way, through the establishment of the Implant Subsidy List (ISL), formerly known as the Medical Technology Subsidy List (MTSL). Implants are a subset of medical technologies that are placed inside or on the surface of the human body1.

The ISL is a list of implants that will be subsidised when used in Public Healthcare Institutions (PHIs) in accordance with the clinical criteria for subsidy eligibility as stipulated in the ISL. 

At present, the ISL includes implants and some related accessories. The ISL will be expanded progressively over time to include other implants across a wide range of specialities.

1The ISL has referenced the definition of implants from the Health Products Act, Health Products (Medical Devices) Regulation 2010.

Download the Implant Subsidy List (accurate as of 1 April 2024)

Frequently Asked Questions

Expand All | Collapse All

1. What is the purpose of ISL?

The ISL aims to extend subsidies to and encourage the use of clinically effective and cost-effective implants to improve patient outcomes and healthcare resource utilisation.

2. What are the criteria for inclusion in this ISL?

The ISL comprises implants that are evaluated to be safe, clinically effective, and cost-effective in treating the identified clinical indications. HSA registration is a pre-requisite for implants to be considered for listing under the ISL.

3. What are the implant categories covered in the ISL? Who is eligible?

Implants will transit to the Implant Subsidy List progressively by implant categories. Within each category, only implants that have been assessed to be clinically- and cost effective will be listed on the Implant Subsidy List.

Implant categories that have transited to the Implant Subsidy List as of 1 Apr 2024

Implant categories currently under assessment as of 1 Apr 2024

• Cardiac Implantable Electronic Devices

• Active Middle Ear Implants

• Bone Conduction Hearing Implants

• Cochlear Implants

• Transcatheter Aortic Valve Implantation Devices

• Transcatheter Mitral Valve Leaflet Repair Devices

• Ossicular Middle Ear Implants

• Hip, Knee and Sports Medicine Implants

• Interventional Cardiology Implants

• Aortic Implants

• Glaucoma Treatment Implants

• Intraocular Lens

• Urogenital Implants

• Gastroenterology Implants

• Vascular Patency and Embolic Management Implants

• Neurovascular Implants

• Vascular Occlusion, Access and Closure Implants

• Spine Implants

• Mammary Implants

• Craniomaxillofacial and Oculoplastic Implants

• Dermal Substitute

• Brachytherapy

• Trauma Implants and Joint (including shoulder, elbow, wrist, finger, ankle, foot) Replacement Implants

• Nerve Stimulation - Deep Brain & Vagal

• Nerve Stimulation - Spinal Cord

• Dural Patch & Aneurysm Clips

4. What are the benefits?

Patients who (i) use implants listed on the ISL and (ii) meet the clinical criteria stated in the ISL, will be eligible for subsidies based on the subsidy framework of the setting where the procedure was performed:

5. Are patients allowed to use implants not listed in the ISL?

Implants that are not listed on the Implant Subsidy List can be broadly classified into two groups:

(1) Implant categories that have yet to transit to the ISL

Patients who use these implants will continue to be eligible for subsidies under the Capped Subsidy Framework:
  • Singapore Citizens: Up to 50%, capped at $1,000
  • Permanent Residents: Up to 25%, capped at $500
(2) Implants that have been assessed to be not clinically- and cost-effective

Patients may use implants that are not listed on the ISL, though this is generally not encouraged. The use of implants that are not clinically- and cost-effective will not be accorded subsidies and patients can expect to pay more. Patients may approach their public healthcare provider to explore subsidised options listed on the ISL.